SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
-11.5%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.63B
AUM Growth
+$2.63B
(-20%)
Cap. Flow
-$267M
Cap. Flow
% of AUM
-10.16%
Top 10 Holdings %
Top 10 Hldgs %
36.43%
Holding
110
New
23
Increased
22
Reduced
18
Closed
21
Top Buys
| 1 |
Canadian Pacific Kansas City
CP
|
$44.3M |
| 2 |
Royalty Pharma
RPRX
|
$44.3M |
| 3 |
XYZ
Block, Inc.
XYZ
|
$41.8M |
| 4 |
Viatris
VTRS
|
$40.6M |
| 5 |
Fidelity National Information Services
FIS
|
$40.6M |
Top Sells
| 1 |
Amazon
AMZN
|
$147M |
| 2 |
Microsoft
MSFT
|
$88.8M |
| 3 |
S&P Global
SPGI
|
$84.8M |
| 4 |
Charles Schwab
SCHW
|
$82.9M |
| 5 |
Johnson & Johnson
JNJ
|
$73.6M |
Sector Composition
| 1 | Healthcare | 56.33% |
| 2 | Industrials | 11.58% |
| 3 | Consumer Discretionary | 10.43% |
| 4 | Technology | 7.11% |
| 5 | Financials | 5.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
101
Charles Schwab
SCHW
$175B
| – | – |
-982,790
| Closed | -$82.9M |
|
102
Natera
NTRA
$23B
| – | – |
-584,660
| Closed | -$23.8M |
|
103
MeiraGTx Holdings
MGTX
$590M
| – | – |
-34,600
| Closed | -$479K |
|
|
104
Johnson & Johnson
JNJ
$429B
| – | – |
-415,310
| Closed | -$73.6M |
|
105
Iovance Biotherapeutics
IOVA
$800M
| – | – |
-406,200
| Closed | -$6.76M |
|
|
INZY
106
DELISTED
Inozyme Pharma
INZY
| – | – |
-1,013,216
| Closed | -$4.14M |
|
107
Deckers Outdoor
DECK
$18.3B
| – | – |
-142,477
| Closed | -$39M |
|
108
Bath & Body Works
BBWI
$6.3B
| – | – |
-1,038,630
| Closed | -$49.6M |
|
109
Aurinia Pharmaceuticals
AUPH
$1.58B
| – | – |
-344,755
| Closed | -$4.27M |
|
|
110
Amazon
AMZN
$2.41T
| – | – |
-45,122
| Closed | -$147M |
|